Homing endonucleases are enzymes that catalyze DNA sequence specific double-strand breaks and can significantly stimulate homologous recombination at these breaks in cells. These enzymes have great potential for applications such as gene correction in gene therapy or gene alteration in systems biology, functional genomics, stem cell engineering, and metabolic engineering. However, homing endonucleases have a limited natural repertoire of target sequences, which severely hampers their applications. The broad and long-term goal of this research is to engineer homing endonucleases that recognize and cleave novel DNA sequences that are linked with human genetic disorders and to investigate the molecular determinants of the exquisite DNA sequence specificity of homing endonucleases. Using a well-characterized homing endonuclease I-SceI as a model system, we will use combinatorial protein engineering strategies to generate I-SceI variants that cleave new target DNA sequences found in a mutant hemoglobin beta gene associated with sickle cell anemia. Such engineered I-SceI mutants hold tremendous potential as novel gene therapy agents for sickle cell anemia. In addition, we will use a variety of biochemical and biophysical methods to characterize select engineered I-SceI variants both in vitro and in mammalian cells. Such studies will provide novel insights into the molecular basis of the homing endonuclease DNA sequence specificity. Equally important, we anticipate that this exploratory/developmental (R21) project will establish a technology platform for engineering a wide variety of DNA-modifying enzymes for biomedical research and human gene therapy. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21HL089418-01A1
Application #
7472038
Study Section
Special Emphasis Panel (ZRG1-GGG-J (10))
Program Officer
Applebaum-Bowden, Deborah
Project Start
2008-04-15
Project End
2010-03-31
Budget Start
2008-04-15
Budget End
2009-03-31
Support Year
1
Fiscal Year
2008
Total Cost
$186,450
Indirect Cost
Name
University of Illinois Urbana-Champaign
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
041544081
City
Champaign
State
IL
Country
United States
Zip Code
61820
Sun, Ning; Zhao, Huimin (2013) Transcription activator-like effector nucleases (TALENs): a highly efficient and versatile tool for genome editing. Biotechnol Bioeng 110:1811-21
Sun, Ning; Abil, Zhanar; Zhao, Huimin (2012) Recent advances in targeted genome engineering in mammalian systems. Biotechnol J 7:1074-87
Chen, Zhilei; Wen, Fei; Sun, Ning et al. (2009) Directed evolution of homing endonuclease I-SceI with altered sequence specificity. Protein Eng Des Sel 22:249-56